International Journal of Inflammation

Acute and Chronic Pancreatic Inflammation

Publishing date
25 May 2012
Submission deadline
25 Nov 2011

Lead Editor

1Department of Surgery, North Manchester General Hospital, Delaunays Road, Manchester M8 5RB, UK

2First Department of Medicine, University of Szeged, P.O. Box: 427, 6701 Szeged, Hungary

3Second Department of Surgery, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland

Acute and Chronic Pancreatic Inflammation


Acute and chronic pancreatitis result in considerable morbidity, are increasing in incidence, and have a high mortality. Due to the inaccessibility of the pancreas to study, our understanding of the pathophysiology of pancreatitis remains limited. Our current knowledge of the evolution of pancreatitis can be described as a progression from an initial acinar cell injury to local and systemic inflammatory responses. If resolution fails to occur, infection or chronicity may supervene.

We invite researchers to contribute original research articles and review articles on topics that shed new insights into the inflammatory processes that occur in pancreatitis. These insights may derive from animal models, studies on the human pancreas, measurement of systemic inflammatory markers, clinical studies, and genetic analyses. Potential topics include, but are not limited to:

  • Genetic polymorphisms and mutations
  • Cytokines and chemokines
  • Transcription factors
  • The heat shock response
  • Autoimmune pancreatitis
  • Neuroimmune interactions
  • SIRS, sepsis, and MODS in acute pancreatitis

Articles published in this special issue will not be subject to the journal's Article Processing Charges.

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

International Journal of Inflammation
 Journal metrics
Acceptance rate13%
Submission to final decision64 days
Acceptance to publication36 days
Impact Factor-

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.